{
  "url": "https://openlegislation.uk/human-medicines-amendment-modular-manufacture-and-point-of-care-regulations-2025/regulation-39",
  "json_url": "https://openlegislation.uk/human-medicines-amendment-modular-manufacture-and-point-of-care-regulations-2025/regulation-39.json",
  "legislation": "uksi/2025/87",
  "legislation_title": "The Human Medicines (Amendment) (Modular Manufacture and Point of Care) Regulations 2025",
  "legislation_url": "https://openlegislation.uk/human-medicines-amendment-modular-manufacture-and-point-of-care-regulations-2025",
  "path": "regulation/39",
  "kind": "regulation",
  "number": "39",
  "heading": "Amendment of regulation 2",
  "text": "In regulation 2(1) (interpretation), at the appropriate places insert—\n““manufacturer’s licence (MM)” has the meaning given in regulation 8(1) of the 2012 Regulations;”;\n““manufacturer’s licence (POC)” has the meaning given in regulation 8(1) of the 2012 Regulations; ”;\n““manufacturing authorisation (MM)” means a manufacturing authorisation that authorises the manufacture or assembly of MM investigational medicinal products;”;\n““manufacturing authorisation (POC)” means a manufacturing authorisation that authorises the manufacture or assembly of POC investigational medicinal products;”;\n““MM” means modular manufacture;”;\n““MM (IMP) control site” means the premises at which the holder of a manufacturing authorisation (MM) supervises and controls the manufacture or assembly of MM investigational medicinal products;”;\n““MM (IMP) master file” means a detailed description of the arrangements for manufacture or assembly of an MM investigational medicinal product;”;\n““MM investigational medicinal product” means an investigational medicinal product that, for reasons relating to deployment, the licensing authority determines it necessary or expedient to be manufactured or assembled in a modular unit;”;\n““modular unit” means a relocatable manufacturing unit;”;\n““POC” means point of care;”;\n““POC (IMP) control site” means the premises at which the holder of a manufacturing authorisation (POC) supervises and controls the manufacture or assembly of POC investigational medicinal products;”;\n““POC (IMP) master file” means a detailed description of the arrangements for the manufacture or assembly of a POC investigational medicinal product;”;\n““POC (IMP) site” means a site at which the manufacture or assembly of a POC investigational medicinal product takes place;”;\n““POC investigational medicinal product” means an investigational medicinal product that, for reasons relating to method of manufacture, shelf life, constituents or method or route of administration, can only be manufactured at or near the place where the product is to be used or administered;”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "Amended by S.I. 2019/744. There are other amendments but none is relevant."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2025/87/regulation/39",
    "retrieved_at": "2026-10-28T21:21:13.963585+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}